相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Aging, cancer, and antitumor immunity
Hideki Ikeda et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2022)
Prognostic Value of the Preoperative Tumor Marker Index in Resected Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Institution Study
Tatsunori Miyata et al.
ANNALS OF SURGICAL ONCOLOGY (2021)
Prognostic value of preoperative glucose to lymphocyte ratio in patients with resected pancreatic cancer
Yueming Zhang et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Association between the baseline frailty and quality of life in patients with prostate cancer (FRAQ-PC study)
Tomoko Hamaya et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Prognostic value of the Memorial Sloan Kettering Prognostic Score in metastatic pancreatic adenocarcinoma
Justin M. Lebenthal et al.
CANCER (2021)
Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1)
Yoichi Naito et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study
Taiga Otsuka et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Survival benefit of adjuvant chemotherapy in elderly patients with colon cancer: a systematic review and meta-analysis
Nobuaki Hoshino et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
The impact of cachexia and sarcopenia in elderly pancreatic cancer patients receiving palliative chemotherapy
Tsuyoshi Takeda et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Frailty status among older critically ill patients with severe acute kidney injury
William Beaubien-Souligny et al.
CRITICAL CARE (2021)
Risk factors for gemcitabine plus nab-paclitaxel-induced interstitial lung disease in pancreatic cancer patients
Tsuyoshi Takeda et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2021)
Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma
Keinosuke Ishido et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2021)
From state-of-the-art treatments to novel therapies for advanced-stage pancreatic cancer
Christopher Nevala-Plagemann et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Prognostic Nutritional Index, Tumor-infiltrating Lymphocytes, and Prognosis in Patients with Esophageal Cancer
Kazuo Okadome et al.
ANNALS OF SURGERY (2020)
Association between preadmission frailty and care level at discharge in older adults undergoing emergency laparotomy
B. Carter et al.
BRITISH JOURNAL OF SURGERY (2020)
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
Eva Versteijne et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Microbiota in pancreatic health and disease: the next frontier in microbiome research
Ryan M. Thomas et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
The tumour microenvironment in pancreatic cancer - clinical challenges and opportunities
Won Jin Ho et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Alterations in driver genes are predictive of survival in patients with resected pancreatic ductal adenocarcinoma
Caitlin A. McIntyre et al.
CANCER (2020)
Prehabilitation prior to surgery for pancreatic cancer: A systematic review
James R. Bundred et al.
PANCREATOLOGY (2020)
Clinical Frailty Scale in Predicting Postoperative Outcomes in Older Patients Undergoing Curative Surgery for Urologic Malignancies: A Prospective Observational Cohort Study
Chien-Yao Sun et al.
UROLOGY (2020)
Frailty is an independent risk factor for recurrence and mortality following curative resection of stage I-III colorectal cancer
Kosuke Mima et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2020)
History of pancreatic surgery in Japan: Respect to the Japanese pioneers of pancreatic surgery
Hiroki Yamaue
ANNALS OF GASTROENTEROLOGICAL SURGERY (2020)
Neoadjuvant treatment for resectable pancreatic adenocarcinoma: What is the best protocol?
Fuyuhiko Motoi et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2020)
Molecular subtypes of pancreatic cancer
Eric A. Collisson et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2019)
Association between frailty syndrome and survival in patients with pancreatic adenocarcinoma
An Ngo-Huang et al.
CANCER MEDICINE (2019)
Potentially Curable Pancreatic Adenocarcinoma: ASCO Clinical Practice Guideline Update
Alok A. Khorana et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Outcomes of Primary Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma
Laura Maggino et al.
JAMA SURGERY (2019)
Clinical Benefit of Preoperative Exercise and Nutritional Therapy for Patients Undergoing Hepato-Pancreato-Biliary Surgeries for Malignancy
Hiroki Nakajima et al.
ANNALS OF SURGICAL ONCOLOGY (2019)
Optimizing the outcomes of pancreatic cancer surgery
Oliver Strobel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Physical activity and exercise during preoperative pancreatic cancer treatment
Nathan H. Parker et al.
SUPPORTIVE CARE IN CANCER (2019)
International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017
Shuji Isaji et al.
PANCREATOLOGY (2018)
Clinical Frailty Scale (CFS) reliably stratifies octogenarians in German ICUs: a multicentre prospective cohort study
Johanna M. Muessig et al.
BMC GERIATRICS (2018)
The 2016 update of the International Study Group (ISGPS) definition and grading of postoperative pancreatic fistula: 11 Years After
Claudio Bassi et al.
SURGERY (2017)
Frailty and Cancer: Implications for Oncology Surgery, Medical Oncology, and Radiation Oncology
Cecilia G. Ethun et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Impact of the Clinical Frailty Scale on Outcomes After Transcatheter Aortic Valve Replacement
Tetsuro Shimura et al.
CIRCULATION (2017)
Adjuvant chemotherapy of S-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01)
Katsuhiko Uesaka et al.
LANCET (2016)
Frailty predicts risk of life-threatening complications and mortality after pancreatic resections
Toms Augustin et al.
SURGERY (2016)
Geriatric Assessment Improves Prediction of Surgical Outcomes in Older Adults Undergoing Pancreaticoduodenectomy
William Dale et al.
ANNALS OF SURGERY (2014)
Randomized Phase III Study of Gemcitabine Plus S-1, S-1 Alone, or Gemcitabine Alone in Patients With Locally Advanced and Metastatic Pancreatic Cancer in Japan and Taiwan: GEST Study
Hideki Ueno et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Impact of an oncogeriatric consulting team on therapeutic decision-making
M. E. Rouge-Bugat et al.
JOURNAL OF NUTRITION HEALTH & AGING (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
The Clavien-Dindo Classification of Surgical Complications Five-Year Experience
Pierre A. Clavien et al.
ANNALS OF SURGERY (2009)
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies
Erik von Elm et al.
LANCET (2007)
A global clinical measure of fitness and frailty in elderly people
K Rockwood et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2005)